Aviva Systems Biology Email Format

Biotechnology ResearchCalifornia, United States11-50 Employees

Aviva Systems Biology is a biotechnology research company headquartered in San Diego, California, employing 11-50 people and serving a global network of distributors. The company maintains a broad catalog of antibodies, ELISAs, and proteins, and offers custom capabilities in recombinant antibody discovery, antibody characterization, protein expression, and assay development for translational and clinical-ready research. It emphasizes integrating discovery, characterization, and measurement to generate reagents and assays that perform with confidence in real sample matrices and relevant applications, with a focus on recombinant antibodies and diagnostic-oriented workflows. Aviva supports scientists worldwide across neuroscience, cancer, immunology, cell biology, and other high-impact research areas. Recent milestones include the launch of Protein on Demand semi-custom recombinant proteins in 2021, the AvivaBlot line of ECL reagents for Western blot in 2022, and the introduction of anti-progranulin recombinant monoclonal antibody clones in 2025.

Sign up for free to view info

Company overview Employee directory